Dear NONMEM users
I am currently performing a time-to-event analysis on binary data using a
weibull distribution (time-varying hazard function).
Using simulation based diagnositcs, I compared `simulated kaplan-Meier` to
`observed kaplan-Meier`. However, fit looks to good to be true and I was
Be influential.
Our Clinical Pharmacology Leads have key roles to play in influencing the
discovery and development of drugs. It is fascinating, vital work and you
could be part of it. Pfizer is a leader in Model Based Drug Development, and
we are expanding its influence in target validation
Dear Francois,
Unless you create a new data set where events are allowed to occur at any
possible time (usually a dense time grid), then the result that you have got
is rather the expected (i.e. too good to be true).
Best regards,
Mats
Mats Karlsson, PhD
Professor of Pharmacometrics